0001683168-24-005773.txt : 20240815
0001683168-24-005773.hdr.sgml : 20240815
20240815161418
ACCESSION NUMBER: 0001683168-24-005773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240813
FILED AS OF DATE: 20240815
DATE AS OF CHANGE: 20240815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Infarinato Robert M.
CENTRAL INDEX KEY: 0002032518
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 241212593
MAIL ADDRESS:
STREET 1: C/O PHIO PHARMACEUTICALS CORP.
STREET 2: 11 APEX DRIVE, SUITE 300A, PMB 2006
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 APEX DRIVE, SUITE 300A
STREET 2: PMB 2006
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 11 APEX DRIVE, SUITE 300A
STREET 2: PMB 2006
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
ownership.xml
X0508
4
2024-08-13
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0002032518
Infarinato Robert M.
C/O PHIO PHARMACEUTICALS CORP.
11 APEX DRIVE, SUITE 300A, PMB 2006
MARLBOROUGH
MA
01752
0
1
0
0
VP, Chief Financial Officer
0
Common stock, $0.0001 par value
2024-08-13
4
A
0
8000
0
A
8000
D
Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date.
Includes shares of common stock underlying unvested restricted stock units.
/s/ Robert M. Infarinato
2024-08-15